Core Viewpoint - Wohl & Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Jamf Holding Corp. for $13.05 per share, which is significantly below the price targets set by various Wall Street analysts [1][2]. Group 1: Proposed Sale Details - The proposed sale price of $13.05 per share is substantially lower than the price targets set by analysts, including $23.00 by Rob Owens at Piper Sandler, $20.00 by Joshua Reilly at Needham, $18.00 by Patrick Walravens at Citizens JMP, and $15.00 by David Hynes at Canaccord Genuity [2]. - Jamf Holding Corp. filed a preliminary proxy with the SEC regarding the proposed sale on November 28, 2025 [2]. Group 2: Investigation and Legal Rights - Wohl & Fruchter LLP is investigating potential conflicts of interest related to the proposed sale and the fairness of the price for shareholders [3]. - Shareholders concerned about the fairness of the sale price are encouraged to contact Wohl & Fruchter LLP to discuss their legal rights at no charge [3]. Group 3: Firm Background - Wohl & Fruchter LLP has over a decade of experience representing investors in litigation related to corporate misconduct and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Semrush Holdings, Inc. to Adobe for $12.00 per share, which is below market expectations and the company's recent performance [1][3]. Group 1: Sale Details - Semrush announced an agreement to be sold to Adobe for $12.00 per share in cash on November 20, 2025 [3]. - The sale price is lower than the $14.00 per share price target set by J.P. Morgan's Mark Murphy and significantly below Semrush's 52-week high of $18.74 per share [1][3]. Group 2: Investigation Purpose - The investigation aims to determine if the Semrush Board of Directors acted in the best interests of shareholders when approving the sale [4]. - It will assess whether the agreed price is fair and if all material information regarding the transaction has been fully disclosed [4].

Core Viewpoint - Wohl & Fruchter LLP has renewed its investigation into the fairness of the proposed sale of WideOpenWest, Inc. (WOW) to DigitalBridge Group and Crestview Partners for $5.20 per share in cash [1] Group 1: Shareholder Dynamics - Crestview Partners is the largest shareholder of WOW, owning approximately 37% of the common stock and has agreed to roll over its equity into the post-close entity, which is not available to public stockholders [2] - The sale was approved based on the recommendation of a purportedly independent special committee of WOW's board, indicating potential conflicts of interest [2] Group 2: Legal Proceedings - On October 27, 2025, WOW filed a definitive proxy with the SEC regarding the proposed sale, prompting the renewal of the investigation by Wohl & Fruchter LLP [3] - Shareholders concerned about the fairness of the sale price are encouraged to contact Wohl & Fruchter LLP for legal discussions at no charge [3] Group 3: Firm Background - Wohl & Fruchter LLP has over a decade of experience representing investors in litigation related to fraud and corporate misconduct, recovering hundreds of millions of dollars for investors [4]

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of Hologic Inc.'s proposed sale to Blackstone and TPG for $76.00 per share in cash, along with a contingent value right (CVR) that could provide an additional $3.00 per share based on future revenue milestones [1][3][4] Group 1: Sale Details - Hologic has agreed to be sold for an upfront payment of $76.00 per share in cash, plus a non-tradeable CVR that could yield up to $3.00 per share if certain revenue targets are met post-closing [1][3] - The proposed sale price is below Hologic's 52-week high of $84.39 per share, leading to disappointment among several investors [2][3] Group 2: Investor Concerns - Investors have expressed concerns regarding the sale price, suggesting it should have been higher given the company's recent business re-acceleration and historical valuation standards [4] - Wohl & Fruchter LLP is examining whether Hologic's Board of Directors acted in the best interests of shareholders in approving the sale and if all material information about the transaction was disclosed [4]

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the sale of Jamf Holding Corp. to Francisco Partners for $13.05 per share, which is significantly lower than its 52-week high of $18.00 per share and below various Wall Street analysts' price targets for the company [1][3]. Group 1: Sale Details - Jamf Holding Corp. has agreed to be sold for $13.05 per share in cash to Francisco Partners [3]. - The sale price is notably below the 52-week high of $18.00 per share [1][3]. Group 2: Analyst Price Targets - Analysts had set price targets for Jamf Holding Corp. significantly higher than the sale price, including $23.00 by Rob Owens at Piper Sandler, $20.00 by Joshua Reilly at Needham, $18.00 by Patrick Walravens at Citizens JMP, and $15.00 by David Hynes at Canaccord Genuity [5]. Group 3: Investigation Focus - The investigation will assess whether the Jamf Board of Directors acted in the best interests of shareholders and if the agreed price is fair [4]. - The inquiry will also look into whether all material information regarding the transaction has been disclosed, including potential conflicts of interest [4].

Core Viewpoint - Wohl & Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Verint Systems for $20.50 per share in cash to Thoma Bravo, raising concerns about potential undisclosed conflicts of interest and the adequacy of the sale price [1][2]. Group 1: Investigation Details - The law firm is examining whether there are any undisclosed potential conflicts of interest and deficiencies affecting the fairness of the sale process [2]. - The investigation follows Verint's filing of a definitive proxy with the SEC regarding the proposed sale [1]. Group 2: Sale Price Concerns - The proposed sale price of $20.50 is below the price targets set by multiple Wall Street analysts prior to the announcement [3]. - The sale price is only $0.03 above Verint's closing stock price of $20.47 on August 22, 2025, the last trading day before the deal announcement [3].

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the sale of Verint Systems, Inc. to Thoma Bravo for $20.50 per share, which is below the price targets set by major Wall Street analysts prior to the announcement [1][3]. Company Summary - Verint Systems, Inc. has agreed to be sold to Thoma Bravo for $20.50 per share in cash [3]. - The sales price is lower than the price targets set by several analysts, including $33.00 by Shaul Eyal of TD Cowen and $30.00 by both Joshua Reilly of Needham and Daniel Ives of Wedbush [5]. Investigation Details - The investigation aims to determine if the Verint Board of Directors acted in the best interests of shareholders and whether the agreed price is fair [3]. - The investigation will also assess if all material information regarding the transaction has been fully disclosed [3].

Core Viewpoint - The law firm Wohl & Fruchter LLP is investigating the fairness of the proposed sale of MeridianLink, Inc. to Centerbridge Partners for $20.00 per share, which is significantly lower than its 52-week high and analyst price targets, indicating a potentially opportunistic acquisition by Centerbridge [1][3]. Group 1: Sale Details - MeridianLink has agreed to be sold to Centerbridge for $20.00 per share in cash [3]. - The sale price is below the 52-week high of $25.33 per share and below the price target of $24.00 set by at least one Wall Street analyst [1][3]. Group 2: Investigation Purpose - The investigation aims to determine if the MeridianLink Board of Directors acted in the best interests of shareholders when approving the sale [4]. - It will assess whether the agreed price is fair and if all material information regarding the transaction has been disclosed [4]. Group 3: Legal Representation - Wohl & Fruchter LLP has a history of representing investors in litigation related to corporate misconduct and has recovered significant damages for investors [4].